INS and Alzheimer disease: MFSs have been reported to act on the insulin pathway, increasing insulin synthesis and reducing inflammation, which was an important reason that motivated us to use it as a potential therapeutic approach for AD (Ma, et al., 2016; Obafemi, et al., 2019).